MSRB1
Basic information
Region (hg38): 16:1938229-1943199
Previous symbols: [ "SEPX1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MSRB1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 8 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 7 | 2 | 0 |
Variants in MSRB1
This is a list of pathogenic ClinVar variants found in the MSRB1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-1940790-A-G | not specified | Uncertain significance (Apr 19, 2024) | ||
16-1940831-G-A | not specified | Uncertain significance (Jan 08, 2024) | ||
16-1940892-C-T | not specified | Uncertain significance (Jul 13, 2022) | ||
16-1941274-T-C | not specified | Uncertain significance (Jan 03, 2024) | ||
16-1941288-C-T | not specified | Uncertain significance (May 13, 2024) | ||
16-1941291-T-C | not specified | Uncertain significance (Jun 17, 2024) | ||
16-1941326-C-T | Likely benign (Jul 31, 2018) | |||
16-1941342-G-A | not specified | Uncertain significance (Dec 09, 2023) | ||
16-1941403-C-T | not specified | Likely benign (Apr 25, 2022) | ||
16-1943116-T-C | not specified | Uncertain significance (Nov 17, 2023) | ||
16-1943135-C-G | not specified | Uncertain significance (Aug 02, 2023) | ||
16-1943143-C-G | not specified | Uncertain significance (May 05, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MSRB1 | protein_coding | protein_coding | ENST00000361871 | 4 | 5117 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.130 | 0.788 | 124707 | 0 | 14 | 124721 | 0.0000561 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.118 | 80 | 77.1 | 1.04 | 0.00000496 | 763 |
Missense in Polyphen | 19 | 22.083 | 0.86037 | 263 | ||
Synonymous | 0.231 | 34 | 35.8 | 0.951 | 0.00000292 | 210 |
Loss of Function | 1.40 | 2 | 5.56 | 0.360 | 2.35e-7 | 69 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000869 | 0.0000869 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000978 | 0.0000972 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Methionine-sulfoxide reductase that specifically reduces methionine (R)-sulfoxide back to methionine. While in many cases, methionine oxidation is the result of random oxidation following oxidative stress, methionine oxidation is also a post- translational modification that takes place on specific residue. Acts as a regulator of actin assembly by reducing methionine (R)- sulfoxide mediated by MICALs (MICAL1, MICAL2 or MICAL3) on actin, thereby promoting filament repolymerization. Plays a role in innate immunity by reducing oxidized actin, leading to actin repolymerization in macrophages. {ECO:0000250|UniProtKB:Q9JLC3}.;
- Pathway
- Selenium Micronutrient Network;Selenium Metabolism and Selenoproteins;Metabolism of proteins;Protein repair
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- 0.06
- rvis_percentile_EVS
- 58.26
Haploinsufficiency Scores
- pHI
- 0.0891
- hipred
- N
- hipred_score
- 0.231
- ghis
- 0.514
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Msrb1
- Phenotype
- cellular phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- response to oxidative stress;actin filament polymerization;protein repair;innate immune response;oxidation-reduction process
- Cellular component
- cellular_component;nucleus;cytosol;actin cytoskeleton
- Molecular function
- actin binding;zinc ion binding;peptide-methionine (R)-S-oxide reductase activity;L-methionine-(R)-S-oxide reductase activity;methionine-R-sulfoxide reductase activity